News

BioNTech and CureVac, two German mRNA companies, have agreed to offer Germany with vaccines for future medical catastrophes for the next many years. Reuters reported that Germany would pay up to 2.86 billion euros ($3.14 billion) to tie in...

Hundreds of businesses have announced a suspension or withdrawal of operations in Russia since its invasion of Ukraine. Some of the most recent companies to join the increasing list were Eli Lilly, Novartis, and AbbVie. Eli Lilly has halted the sale...

Only about half of women infected with ovarian cancer survive five years after diagnosis. AstraZeneca is partnering with a group of doctors and a network of patient advocacy groups to try to reverse this grim figure. The pharma behemoth...

After the US Food and Drug Administration postponed essential steps toward legalising COVID-19 vaccinations for children under the age of five by a month, many parents are more eager and enthused than ever. People are driving in from multiple states...

Thanks to a deal reached by NHS England, a targeted new medicine for a rare and severe form of lung cancer will be accessible to qualified patients within weeks. Mobocertinib, the only precision medicine accessible to patients with a...

Patrick McGrath brings more than 20 years of cold chain industry experience to the role Peli BioThermal, the life science industry’s cold chain partner from discovery to distribution, announces Patrick McGrath as its new Director of Sales, Americas. McGrath will...

Pfizer and BioNTech announced Tuesday that they have filed an application to the US Food and Drug Administration for urgent use permission of an extra booster dose of their COVID-19 vaccine for adults 65 or older who have already...